<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2018.9418</article-id>
<article-id pub-id-type="publisher-id">mmr-18-05-4767</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>BIRC5 is a novel target of peroxisome proliferator-activated receptor &#x03B3; in brain microvascular endothelium cells during cerebral ischemia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Xu</surname><given-names>Mingjing</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Yang</surname><given-names>Xianli</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Zeng</surname><given-names>Qing</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>He</surname><given-names>He</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Lu</surname><given-names>Pengcheng</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Huang</surname><given-names>Guozhi</given-names></name></contrib>
</contrib-group>
<pub-date pub-type="ppub"><month>11</month><year>2018</year></pub-date>
<pub-date pub-type="epub"><day>22</day><month>08</month><year>2018</year></pub-date>
<volume>18</volume>
<issue>5</issue>
<fpage>4767</fpage>
<lpage>4767</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; Xu et al.</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Mol Med Rep 16: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="16" page="8882" id="RA1" xlink:href="10.3892/mmr.2017.7750" ext-link-type="doi">8882-8890</related-article>, 2017; DOI: 10.3892/mmr.2017.7750</p>
<p>The authors of the above article wish to retract their paper. Subsequently to its publication, in addition to certain irreconcilable differences in opinion shared among the authors, they have realized that, in their analysis of the role of peroxisome proliferator-activated receptor &#x03B3; in brain microvascular endothelial (bEnd.3) cells, certain of the results presented have been found to be incomplete and unrepeatable. Therefore, they wish to retract the paper in order to maintain the integrity of the scientific record.</p>
<p>The authors regret any inconvenience that this retraction will caused to the Editor of the journal, and the readership.</p>
</body>
</article>